A Study of CHS-1000 in Participants With Advanced or Metastatic Solid Tumors

NCT06389526 · clinicaltrials.gov ↗

PHASE1

Phase

NOT_YET_RECRUITING

Status

48

Enrollment

INDUSTRY

Sponsor class

Conditions

Advanced or Metastatic Solid Tumors

Interventions

BIOLOGICAL: CHS-1000
BIOLOGICAL: Toripalimab

Sponsor

Coherus Oncology, Inc.